Delivery Order SPE2DB22D2006-SPE2DB24FW2GP
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Meropenem-0.9% Sodium Chloride 1 gram/50s to the Defense Logistics Agency (DLA). The contract, valued at $1,399.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,098.80 firm fixed-price delivery order is for the supply of 4561053561 - Meropenem-0.9% Sodium Chloride 1 Gram/50s, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,196.33 firm fixed-price delivery order is for the supply of Meropenem-0.9% Sodium Chloride 1 gram/50 units, a critical antibiotic medication. The contract has a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,746.66, is for the supply of 4567008715 - Meropenem-0.9% Sodium Chloride 1 Gram/50s. The contract is a firm fixed-price award with an ultimate completion date of January 23, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,180.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,519,366 units of Meropenem 2 gram vials, a critical antibiotic medication. The contract has a fixed-price delivery order structure and an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,625.71, is for the supply of MEROPENEM-0.9% NACL 1 GRAM/50S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,697,433 units of the pharmaceutical drug meropenem, a 2 gram vial. The contract has a total potential value of $2,440.78 and a completion date of February 20, 2024. This delivery order contract is not...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division was made by the Medical Supply Chain component of the Defense Logistics Agency (DLA). The $1,159.20 firm fixed price delivery order is for the supply of 1 gram vials of the antibiotic Ertapenem. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,270.06, is for the delivery of Ertapenem 1 Gram Vials, a pharmaceutical product. The award has a completion date of February 15, 2024 and is structured as a Firm Fixed Price Delivery Order contract. This contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...